Bremelanotide in women with hypoactive sexual desire disorder: pooled phase 3 analysis
Sexual Medicine
2020
Study summary
Pooled analysis of phase 3 bremelanotide trials in premenopausal women with HSDD.
Key findings
Bremelanotide improved desire and reduced distress compared with placebo.
Study details
Study type
clinical trial analysis
Journal
Sexual Medicine
DOI / PubMed
10.1016/j.jsxm.2020.07.004
Year
2020
Explore peptide profiles
Discover compounds, understand their mechanisms, and explore the research behind each peptide.